We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 154.21 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDM0Y7T
RNS Number : 2600J
Northern Trust Corporation
08 April 2020
Ap19
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Hot Features
Premium
1. KEY INFORMATION
Name of person dealing Northern Trust Corporation
(Note 1)
Company dealt in AbbVie Inc
===========================
Class of relevant security Common Stock USD 0.01
to which the dealings
being disclosed relate
(Note 2)
===========================
Date of dealing 7(th) April 2020
===========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
========= ====== =========== ======
22,082,844
(1) Relevant securities 1.49%
================= ===================
(2) Derivatives (other
than options)
================= ===================
(3) Options and agreements
to purchase/sell
================= ===================
22,082,844
Total 1.49%
================= ===================
Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 131 securities into the relevant accounts and 600 securities out of the relevant accounts.
(b) Interests and short positions in relevant securities of the company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap20
1. DEALINGS (Note 4) *
(a) Purchases and sales
BUY 187 75.39
BUY 9 75.39
------ -------
BUY 42 75.39
------ -------
SELL 12 77.64
------ -------
BUY 4611 75.39
------ -------
SELL 35 77.64
------ -------
BUY 180 1
------ -------
BUY 375 77.15
------ -------
SELL 1653 1
------ -------
BUY 9 77.62
------ -------
BUY 1295 77.489
------ -------
SELL 6 77.64
------ -------
SELL 29 77.64
------ -------
SELL 18 77.64
------ -------
SELL 20 77.64
------ -------
BUY 44 77.62
------ -------
BUY 34 77.62
------ -------
SELL 23 77.64
------ -------
SELL 266 77.82
------ -------
SELL 4 77.64
------ -------
SELL 7 77.64
------ -------
SELL 163 77.64
------ -------
BUY 43 77.62
------ -------
SELL 553 1
------ -------
SELL 4 77.64
------ -------
BUY 7 77.62
------ -------
BUY 47 75.39
------ -------
SELL 1102 1
------ -------
SELL 20 77.64
------ -------
BUY 990 77.15
------ -------
SELL 85 77.64
------ -------
SELL 9 77.64
------ -------
SELL 43 75.39
------ -------
SELL 6 77.64
------ -------
BUY 12478 77.15
------ -------
SELL 19 77.64
------ -------
BUY 49 75.39
------ -------
SELL 5 77.64
------ -------
BUY 29014 77.489
------ -------
SELL 5 77.64
------ -------
SELL 305 1
------ -------
BUY 10 77.62
------ -------
BUY 23 77.62
------ -------
BUY 23 75.39
------ -------
SELL 29 77.64
------ -------
BUY 20 75.39
------ -------
BUY 9967 77.15
------ -------
BUY 33 75.39
------ -------
SELL 57 77.64
------ -------
BUY 4270 75.39
------ -------
BUY 421 75.39
------ -------
SELL 186 75.39
------ -------
SELL 8 77.64
------ -------
SELL 39 77.64
------ -------
SELL 102 75.58
------ -------
BUY 200 78.09
------ -------
SELL 58 77.04
------ -------
SELL 29 77.04
------ -------
SELL 70 76.98
------ -------
SELL 10 77.53
------ -------
SELL 7500 77.785
------ -------
SELL 4300 77.785
------ -------
SELL 400 77.56
------ -------
BUY 14 77.15
------ -------
BUY 6 77.15
------ -------
BUY 6 77.15
------ -------
BUY 2 77.15
------ -------
BUY 2 77.06
------ -------
SELL 20 76.86
------ -------
BUY 5 77.15
------ -------
BUY 24 77.15
------ -------
SELL 276 77.9
------ -------
SELL 405 77.9
------ -------
BUY 44 77.15
------ -------
BUY 38 77.15
------ -------
BUY 4 77.15
------ -------
BUY 12 77.15
------ -------
BUY 19 77.15
------ -------
BUY 7 77.15
------ -------
SELL 8 75.52
------ -------
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 8(th) April 2020
Contact name Geoffrey Doggart
=================
Telephone number 0207 982 1783
=================
If a connected EFM, name
of offeree/offeror with
which connected
=================
If a connected EFM, state
nature of connection (Note
10)
=================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEUWVORRAUSRAR
(END) Dow Jones Newswires
April 08, 2020 09:53 ET (13:53 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
